up to now few years, the united kingdom has witnessed a revolution in medical excess weight‑decline treatments — in the introduction of semaglutide (Wegovy®) on the escalating popularity of tirzepatide (Mounjaro®). Now, Yet another identify is drawing consideration in the two clinical and general